Targeting of mRNA vaccines to antigen-presenting cells via central immunoreceptor
The success of mRNA vaccines against the SARS-CoV-2 virus during the pandemic highlighted the potential of the technology and opened the door for applications beyond vaccines. However, the low degree of immune response observed in some individuals necessitates continued improvement in the technology. One promising approach is to target the vaccine delivery to specific cells involved in the immune
